Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-026933
Filing Date
2025-08-14
Accepted
2025-08-14 16:09:35
Documents
81
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q omer20250630_10q.htm   iXBRL 10-Q 1554306
2 EXHIBIT 31.1 ex_822300.htm EX-31.1 12796
3 EXHIBIT 31.2 ex_822301.htm EX-31.2 13454
4 EXHIBIT 32.1 ex_822302.htm EX-32.1 6502
5 EXHIBIT 32.2 ex_822303.htm EX-32.2 6523
  Complete submission text file 0001437749-25-026933.txt   8878980

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA omer-20250630.xsd EX-101.SCH 83652
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20250630_def.xml EX-101.DEF 585077
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20250630_lab.xml EX-101.LAB 457475
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20250630_pre.xml EX-101.PRE 612601
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omer-20250630_cal.xml EX-101.CAL 55016
84 EXTRACTED XBRL INSTANCE DOCUMENT omer20250630_10q_htm.xml XML 1551873
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 251219019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)